|
Growing Prevalence of Asthma is Fueling Vigorous Industry Competition for …
RedOrbit Respiratory drug leader GSK presented largely positive results from five pivotal Relvar (formerly Relovair) asthma trials. The results, submitted in July as part of the company's regulatory filing for asthma in the EU, demonstrated improved efficacy … |
View full post on asthma – Google News